Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Frier

Showing results (251-260 of 442) with videos related to

Pageof 45
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|August 30, 2007
Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemiaAndrew J Sommerfield, Ian B Wilkinson, David J Webb, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 13, 2005
Preparation of Tc-99m-macroaggregated albumin from recombinant human albumin for lung perfusion imagingA P Hunt, M Frier, R A Johnson, et al.
Diabetes, Obesity & Metabolism|October 15, 2019
Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mLWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Nuclear Medicine Communications|August 1, 1990
111In platelet deposition following peripheral arterial thrombolysisD C Berridge, M Frier, M Wastie, et al.
Archives of Disease in Childhood|January 25, 2005
Pubertal stage and hypoglycaemia counterregulation in type 1 diabetesL A Ross, R E Warren, C J H Kelnar, et al.
Clinical Science (London, England : 1979)|April 1, 1991
Autonomic mechanisms underlying intraocular pressure changes during insulin-induced hypoglycaemia in normal human subjects: effects of pharmacological blockadeD A Hepburn, B M Fisher, I Thomson, et al.
Diabetes, Obesity & Metabolism|June 27, 2018
Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin-naive individuals with type 2 diabetes mellitusBrian M Frier, Wolfgang Landgraf, Mei Zhang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 27, 2001
Cognitive function and information processing in type 2 diabetesR Cosway, M W Strachan, A Dougall, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
Effects of acute hypoglycemia on motivation and cognitive interference in people with type 1 diabetesVincent McAulay, Ian J Deary, Andrew J Sommerfield, et al.
Primary Care Diabetes|May 4, 2023
Response to insulin glargine 100 U/mL treatment in newly-defined subgroups of type 2 diabetes: Post hoc pooled analysis of insulin-naïve participants from nine randomised clinical trialsWolfgang Landgraf, Gregory Bigot, Brian M Frier, et al.
Pageof 45

Showing results (251-260 of 442) with videos related to

Sort By:
Pageof 45
American Journal of Physiology. Endocrinology and Metabolism|August 30, 2007
Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemiaAndrew J Sommerfield, Ian B Wilkinson, David J Webb, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 13, 2005
Preparation of Tc-99m-macroaggregated albumin from recombinant human albumin for lung perfusion imagingA P Hunt, M Frier, R A Johnson, et al.
Diabetes, Obesity & Metabolism|October 15, 2019
Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mLWolfgang Landgraf, David R Owens, Brian M Frier, et al.
Nuclear Medicine Communications|August 1, 1990
111In platelet deposition following peripheral arterial thrombolysisD C Berridge, M Frier, M Wastie, et al.
Archives of Disease in Childhood|January 25, 2005
Pubertal stage and hypoglycaemia counterregulation in type 1 diabetesL A Ross, R E Warren, C J H Kelnar, et al.
Clinical Science (London, England : 1979)|April 1, 1991
Autonomic mechanisms underlying intraocular pressure changes during insulin-induced hypoglycaemia in normal human subjects: effects of pharmacological blockadeD A Hepburn, B M Fisher, I Thomson, et al.
Diabetes, Obesity & Metabolism|June 27, 2018
Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin-naive individuals with type 2 diabetes mellitusBrian M Frier, Wolfgang Landgraf, Mei Zhang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 27, 2001
Cognitive function and information processing in type 2 diabetesR Cosway, M W Strachan, A Dougall, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
Effects of acute hypoglycemia on motivation and cognitive interference in people with type 1 diabetesVincent McAulay, Ian J Deary, Andrew J Sommerfield, et al.
Primary Care Diabetes|May 4, 2023
Response to insulin glargine 100 U/mL treatment in newly-defined subgroups of type 2 diabetes: Post hoc pooled analysis of insulin-naïve participants from nine randomised clinical trialsWolfgang Landgraf, Gregory Bigot, Brian M Frier, et al.
Pageof 45